Showing 1 - 2 of 2
Persistent link: https://www.econbiz.de/10011305030
Aim of this paper is to discuss the issue of corporate structure and business models for managing new modular and complementary biotechnology innovations. Corporate structure and business models of Large Diversificated Firms (LDFs) and Dedicated Biotechnology Firms (DBFs). In fact, are at the...
Persistent link: https://www.econbiz.de/10013100612